Azienda Sociosanitaria ASL 1 ,Imperia Trials

Azienda Sociosanitaria ASL 1 ,Imperia	Welcome, Profile Billing Logout

Azienda Sociosanitaria ASL 1 ,Imperia

Welcome, Profile Billing Logout

0 Trials

2 Trials

Active Trials

Export

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Cenderello, Giovanni

ACTIV-4, NCT04505774 / 2020-004285-19: Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 ACUTE

Completed

3591

Europe, US, RoW

theraputic heparin, unfractionated heparin, Enoxaparin, Dalteparin, Tinzaparin, Heparin, prophylactic heparin, enoxaparin, dalteparin, Fondparinux, P2Y12, Ticagrelor, Prasugrel, Clopidogrel, Crizanlizumab Injection, SGLT2 inhibitor, dapagliflozin, empagliflozin, canagliflozin, ertugliflozin

Matthew Neal MD, National Heart, Lung, and Blood Institute (NHLBI)

Covid19

08/23

01/24

AEQUI, NCT04825132: Infectious Diseases in Aged Population

Completed

N/A

521

Europe

Geriatric assessment tools

University Hospital, Grenoble

Respiratory Infections in Old Age, Bacteremia

11/23

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Cenderello, Giovanni

ACTIV-4, NCT04505774 / 2020-004285-19: Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 ACUTE

Completed

3591

Europe, US, RoW

Matthew Neal MD, National Heart, Lung, and Blood Institute (NHLBI)

Covid19

08/23

01/24

AEQUI, NCT04825132: Infectious Diseases in Aged Population

Completed

N/A

521

Europe

Geriatric assessment tools

University Hospital, Grenoble

Respiratory Infections in Old Age, Bacteremia

11/23

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites